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Viral RNAInﬂuenza virus has a segmented genome composed of eight negative stranded RNA segments. Each segment is
covered with NP forming ribonucleoproteins (vRNPs) and carries a copy of the heterotrimeric polymerase
complex. As a rare phenomenon among the RNA viruses, the viral replication occurs in the nucleus and
therefore implies interactions between host and viral factors, such as between importin alpha and
nucleoprotein. In the present studywe report that through binding with the human nuclear receptor importin
α5 (Impα5), the viral NP is no longer oligomeric but maintained as a monomer inside the complex. In this
regard, Impα5 acts as a chaperone until NP is delivered in the nucleus for viral RNA encapsidation. Moreover,
we show that the association of NP with the host transporter does not impair the binding of NP to RNA. The
complex human Impα5-NP binds RNAwith the same afﬁnity as wt NP alone, whereas engineered monomeric
NP through point mutations binds RNA with a strongly reduced afﬁnity.Meyerhofstrasse 1, D-69117
l rights reserved.© 2010 Elsevier Inc. All rights reserved.Introduction
Inﬂuenza A viruses are important viral pathogens of humans and
animals. Despite the seasonal character of the disease, human
pandemics also occur. Last year's swine origin H1N1 pandemic has
clearly demonstrated that outbreaks can occur suddenly and
unexpectedly despite constant worldwide surveillance. The current
highly virulent H5N1 avian strain circulating in Asia may as well adapt
to man and become a serious threat for the worldwide population. For
these reasons, we should maintain our efforts to understand why and
how inﬂuenza virus can adapt to humans and more precisely which
host cell proteins are hijacked by the virus for its own purpose.
Inﬂuenza A viruses are enveloped viruses of the orthomyxovirus
family whose genome comprises 8 negative strand RNA segments.
Together with a copy of the heterotrimeric polymerase, the viral
nucleoprotein (NP) forms ribonucleoprotein (RNP) complexes with
the viral RNA with a stoichiometry of one NP protomer for 24
nucleotides (Compans et al., 1972; Ortega et al., 2000). During
infection, the incoming RNPs are released in the cytoplasm and are
then actively imported into the nucleus where transcription and
replication take place (Whittaker et al., 1996). Viral replication is notpossible without this nucleoprotein, i.e. the nucleoprotein–vRNA
complex is the template for the viral polymerase (Bishop et al., 1971).
The inﬂuenza A virus nucleoprotein is 498 amino acids long (56 kDa)
and is positively charged. As expected from its role in the formation of
the RNPs, NP has been shown to possess a high afﬁnity for ssRNAwith
no sequence speciﬁcity (Baudin et al., 1994; Digard et al., 1999;
Kingsbury et al., 1987; Scholtissek and Becht, 1971; Yamanaka et al.,
1990). In viral RNP or in a reconstituted NP-RNA complex, RNA binds
to NP through its phosphate-sugar backbone (Baudin et al., 1994). The
interaction between NP and RNA has been shown to be cooperative
(Yamanaka et al., 1990). However, the delivery process of NP on the
viral RNA template remains unknown.
The atomic structure of recombinant NP free of RNA was recently
determined (Ye et al., 2006). The structure of the nucleoprotein shows
three domains (Fig. 1), a helical Body domain (residues 21 to 149;
residues 273 to 396 and residues 453 to 489), a helical Head domain
(residues 150 to 272 and residues 438 to 452), and a C-terminal Tail
domain (residues 402 to 428). The Tail domain is involved in domain
exchange and protein oligomerization. The putative RNA-binding site
is located between the Head and Body domains. A large number of
basic residues present in this region could constitute the RNA binding
platform (Ng et al., 2008). The RNA would be largely exposed on the
external surface of nucleoprotein molecules in the RNP; consistent
with the fact that inﬂuenza virus RNA covered with nucleoprotein is
still sensitive to RNases (Baudin et al, 1994; Duesberg, 1969).
Fig. 1. Structure of inﬂuenza A virus nucleoprotein and location of R416 and E339 (PDB
accession number 2IQH). The Head domain is coloured in blue, the Body domain is
coloured in green and the Tail domain is coloured in orange. The two residues R416 and
E339 are indicated in black.
Fig. 2. Electron micrographs of negatively stained inﬂuenza virus nucleoprotein recNP;
recombinant wild type NP produced in E. coli. monoNP; recombinant NPmutant R416A.
Negative staining was done with 2% uranyl acetate.
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adaptation and pathogenesis when an avian virus changes host to a
mammalian species (Chen et al., 2006; Gabriel et al., 2005, 2008;
Naffakh et al., 2008; Nagata et al., 2008). Indeed, inﬂuenza
transcription, translation, and protein trafﬁcking are dependent on
the host machinery. A multitude of cellular factors interacting with
inﬂuenza virus polymerase and nucleoprotein are being identiﬁed
(Watanabe et al., 2010). Subsequent to viral protein translation in the
cytoplasm, NP and polymerase need to be actively transported into
the nucleus. This transport is achieved through importin α binding,
which recognizes the NLSmotif present at the surface of the protein to
be imported. Then this complex binds in turn to importin β that
directs the complex through the nucleopore (reviewed by Cook et al.,
2007).
Different studies have already shown that isolated inﬂuenza
nucleoprotein interacts in vivo and in vitro with several human
importins α such as α1, α3 and α5 (O'Neill et al., 1995; Wang et al.,
1997; Melen et al., 2003). NPwas shown to possess a non-conventional
NLS present in its N-terminal region (amino acids 1-13) (Wang et al.,
1997; Neumann et al., 1997) and/or a classical bipartite NLS between
amino acids 198 and 216 (Weber et al., 1998), although some evidence
favours the use of the N-terminal signal only (Cros et al., 2005).
Moreover, the crystal structure of NP (Ye et al., 2006; Ng et al., 2008)
shows a distance of 15 Å between the two basic clusters 198-KR-199
and 213-RKTR-216. This length is clearly shorter than the minimal
required distance of 28 Å necessary for the efﬁcient binding of importin
alpha (Fontes et al., 2000).Unfortunately, theﬁrst twenty aminoacids of
NP are not visible in the crystal structure of NP.
In the present work, we studied the interactions of inﬂuenza virus
NP with human importin alpha 5 (Impα5) as well as the binding of
RNA to NP and to NP inside the NP–Impα5 complex. We show
through biochemical assays that Impα5 maintains NP as a monomer
and that the RNA binding activity inside the NP–Impα5 complex is
preserved. Mutated monomeric NP binds with a 20 times lower
afﬁnity to RNA than wt recombinant NP. However, NP associated with
importin alpha binds to viral RNA with the same afﬁnity as wt NP,
suggesting that monomerisation is not responsible for the decreased
afﬁnity. The mutations engineered on NP (R416A and E339A) are
responsible for the observed low afﬁnity to RNA which could be the
consequence of a conformational change of NP leading to a change in
the RNA binding platform.Results
Recombinant wt and monomeric NP
Recombinant inﬂuenza virus NP (recNP) with an N-terminal
histidine-tag (His-Tag) was expressed in Escherichia coli and puriﬁed
according to a previously published protocol (Baudin et al., 1994).
Monomeric inﬂuenza virus NP (monoNP) was made by mutating
R416 or E339 to alanines. The crystal structure of NP (Ye et al., 2006)
shows a Tail domain (Fig. 1) that is involved in the oligomerization of
the NP protomers. The interaction between NP protomers is stabilized
by a salt-bridge between arginine R416 of one protomer and
glutamate E339 from a second NP protomer. The mutation of R416
and E339 to alanine destroys the salt-bridge and leads to monomeric
NP. The importance of amino acid R416 in the oligomerization process
was ﬁrst described by Elton et al. (1999a). The polymerisation state of
these two nucleoprotein preparations was ﬁrst visualised using
negative stain electron microscopy (Fig. 2). The NP samples were
ﬁrst incubated at 37 °C for 10 min, then stained with a freshly
prepared 2% uranyl-acetate solution. Images were taken with a
Morgagni FEI electron microscope at 100 kV with a magniﬁcation of
71,000 times. RecNP forms small oligomers with many monomers,
dimers, trimers and tetramers in the background as pointed out in
white circles (Fig. 2 recNP). As expected, the R416A and the E339
mutant NP only produced monomers (Fig. 2 monoNP, only the result
for the R416 mutant is shown).
Binding of inﬂuenza NP to the host factor importin α5 (Impα5)
Importin α5 was produced and puriﬁed as described before
(Tarendeau et al., 2007, see Materials and methods). Since both wild
type recNP and recombinant Impα5 were individually expressed and
puriﬁed through an N-terminal His-tag as a ﬁrst step of puriﬁcation,
we removed one of the tags in order to purify the complex. Since NP
polymerises easily, we used a three times excess of Impα5 over recNP
(w/w) in order to shift the NP oligomerization towards NP–Impα5
hetero-dimer formation. Therefore, the His-tag was kept on NP in
order to get rid of the excess of Impα5 protein. The two puriﬁed
proteins were mixed and puriﬁed over a Co2+ charged afﬁnity
column. After complex elution, an exclusion size chromatographywas
performed (Fig. 3a). The ﬁrst peak elutes at 9.1 ml and corresponds to
the void volume of the column. The second peak elutes at 11.2 ml and
most likely contains small aggregates such as dimers or trimers of NP
as well as dimers of importin α5 as seen on an SDS gel (Fig. 3b,
Fig. 3. Interaction of recNP with importin α5. (a) Elution proﬁle from a Superdex 200
column (GE Healthcare) of the recNP–Impα5 complex. The molecular weights of the
proteins that were used for the calibration of the column (protein standards from
Amersham Biosciences: ferritin (440 kDa), catalase (232 kDa), aldolase (158 kDa),
albumin(67 kDa), ovalbumin (43 kDa), chymotrypsin (25 kDa); vv=void volume) are
indicated above the elution proﬁle. (b) SDS gel of fractions 5 and 7–9 of the elution proﬁle
shown in panel 3a. (c) Analytical ultracentrifugation experiment on the recNP–Impα5
complex, fraction 8 from the elution shown in panel a. The plot shows the sedimentation
coefﬁcient distribution derived from sedimentation velocity proﬁle using SEDFIT.
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corresponding to recNP and Impα5 as seen on the SDS gel (Fig. 3b,
fractions 7–9) and we estimate that the two bands on the SDS gel in
Fig. 3b have a similar intensity. According to the calibration of the
S200 column, indicated above the elution proﬁle in Fig. 3a, an elution
volume of 14.3 ml corresponds to that of a spherical protein with aFig. 4. Characterization of the monoNP–Impα5 complex. a) Elution proﬁles on a preparative
(green curve) and the incubation mixture between monoNP and Impα5 (red curve). b) SDS
shown in a. c) analytical ultracentrifugation experiments on monoNP, Impα5 alone and I
sedimentation coefﬁcient distribution derived from sedimentation velocity proﬁle using SEsize of roughly 100 kDa, in agreement with the expected molecular
weight of the complex; i.e. 58 kDa for the recombinant NP (including
His-tag) plus 50 kDa for importin α5. We veriﬁed the size of the
complex in fraction 8 by analytical ultra centrifugation (Fig. 3c) and
found that it sedimented with a size of 106 kDa. Therefore, the two
proteins are present in equimolar amounts in the complex. This result
suggests that recNP is no longer oligomeric upon association with
Impα5, implying that importin α5 binding impairs the binding of free
recNP to the NP–Impα5 dimer.
We also characterized the interaction between monomeric R416A
NPmutant and importinα in vitro. ThemonoNP alonewasﬁrst injected
on a size exclusion chromatography (gelﬁltration S200, Pharmacia) and
the curve shows a single peak eluting at 214 ml (Fig. 4a and b, black
curve). Importinα5 alone (green curve) was then injected on the same
columnand shows a peak eluting at 200 ml (Fig. 4a and b). Injection of a
mixture of monoNP and impα5 (red curve) shows 3 peaks on the size
exclusion chromatography (Fig. 4a). The ﬁrst one corresponds to the
void volume of the column (110 ml). The second peak elutes at 174 ml
and the thirdpeakelutes at 214 ml. Aliquots from fractionsof theelution
curve were applied to an SDS gel and shows the presence of monoNP
and Impα5 in peak 2 and the presence of monoNP in excess in peak 3
(Fig. 4a and b). Here again, we estimate that the two bands from peak 2
on the SDS gel in Fig. 4b present a similar intensity. Therefore, the two
proteins appear to be present in equimolar amounts in the complex.We
again performed analytical ultracentrifugation experiments to deter-
mine precisely the molecular weight of the complex. Fig. 4c shows the
sedimentation proﬁle of R416A NP alone with a molecular weight of
56 kDa, conﬁrming the electron microscopy result. Importin α5
sediments with a molecular weight of 50 kDa and the ultracentrifuga-
tion experiment performed on the R416A NP–Impα5 complex reveals
the same molecular weight as that for the wt recNP–Impα5 complex.
We then determined the binding afﬁnity of inﬂuenza NP to
importin α5 using an ITC experiment (isothermal calorimetry) as
shown in Fig. 5. Such experiment cannot be performed with wt recNP
because the heat effects of NP-NP interactions interfere with those of
the NP–Impα5 interaction. MonoNP binds to importin α5 with an
afﬁnity of 26 nM. This value is very similar to the afﬁnities measured
for other nuclear import substrates for their receptors (Yang et al.,
2010).
RNA binding to NP and NP–Impα5 complex
The afﬁnity of both recNP and monoNP for panhandle RNA was
measured by a ﬁlter binding assay. Panhandle RNA is an 81 nt RNA
molecule comprising the conserved 3' and 5' ends of inﬂuenza A vRNA
connected by a sequence derived from the NP gene (Baudin et al.,
1994). In ﬁlter binding experiments, a very small amount of
radioactively labelled RNA is mixed with increasing concentrations
(from 10−9 M to 10−4 M) of NP. The mixture is then ﬁltered through
presoaked nitrocellulose membrane and only RNA that is bound to NP
is retained on the ﬁlter and can be counted by Cerenkov counting.
Since the amount of RNA used was extremely small (0.03 pmol), the
NP concentration at 50% retention corresponds to the apparent
dissociation constant Kd. The results are shown in Fig. 6a. Wild type
recNP binds to panhandle RNA with an afﬁnity of 3.8×10−7 M.
However, the monomeric mutant R416A binds RNA with a more than
tenfold lower afﬁnity (Kd 2.6×10−6 M). Similarly, the E339A mutant
binds to panhandle RNA with an afﬁnity of 1.6×10−6 M. We further
analyzed if RNA was able to bind to importin α5 or to the NP–Impα5
complex, see Fig. 6b. The importin alone did not bind RNA but the
complex bound with an afﬁnity identical to that of wt NP alone;S200 column of the inﬂuenza NP R416A mutant (monoNP) (black curve), Impα5 alone
gels of the black (monoNP), green (Impα5) and red (monoNP–Impα5) elution proﬁles
mpα5 in complex with monoNP (second peak in the proﬁle in a. The plot shows the
DFIT. The protein concentration for the 3 different species was 0.8 mg/ml.
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the binding thermodynamics of monoNP to human Impα5. Titration of 126 μM
monoNP (R416A) into a solution of 11 μM Impα5. The experiments were performed in
40 mM Tris–HCl buffer, pH 7.5, 200 mM NaCl and 1 mM β-mercaptoethanol at 25 °C.
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The shapes of the two curves are very similar and these results suggest
that importin α binding to inﬂuenza NP leaves the RNA binding
platform on NP accessible.
Discussion
The gene for the recombinantNPused in thisworkwas isolated from
the A/PR/8/34 strainwhereas the nucleoprotein used by Ye et al. (2006)
was from the A/WSN/33 strain. Although strain speciﬁc differencesmay
exist in the polymerization state of isolated NP (Ye et al., 2006), our
results are in general agreement with those of Ye and coworkers that
most of the protein exists as small oligomers going from monomers to
trimers and tetramers with only a few larger aggregates. These results
are alsomore or less in agreementwith those on NP isolated fromA/PR/
8/34 virus and prepared for EM under the same conditions (incubation
at 37 °C) (see Fig. 2b in Ruigrok and Baudin, 1995). We also conﬁrmed
the results by Elton et al. (1999a) and Ye et al. (2006) on themonomeric
state of the R416A mutant. R416 forms a salt bridge with E339 in the
crystal structures of the NP trimer (Ye et al., 2006; Ng et al., 2008) and
we showhere that the E339Amutant is alsomonomeric, conﬁrming the
crucial role for this salt bridge in trimer formation.
Wild type recombinant NP binds to RNA with an afﬁnity 10 times
lower than NP isolated from A/PR/8/34 virus (Kd 3.8×10−7 M for
recombinant NP vs. 3.7×10−8 M for viral NP, both measured with the
same 81 nt panhandle RNA (Baudin et al., 1994). The experiment with
viral NPwas repeatedwith the same result (not shown). For recNP the
presence or absence of an N-terminal His-tag did not inﬂuence the
afﬁnity for RNA. We do not have a clear cut explanation for the
difference in RNA afﬁnity between NP isolated from virus and recNP.
We did ﬁnd, however, that viral NP is phosphorylated to some extendwhereas recombinant NP is not (not shown). The two monomeric NP
mutants bind RNA with an even lower afﬁnity; 2.6 and 1.6×10−6 M
for R416A and E339A, respectively. This could be due to the fact that
these proteins cannot oligomerize onto the RNA (Chan et al., 2010), or
to the fact that these mutations lead to a conformational change of NP
or to the fact that the RNA binding platform is affected by these
mutations. Elton et al. (1999b) performed UV cross-linking experi-
ments on the binding properties of NP for RNA. Using this technique,
they could not detect RNA binding to R416A at 37 °C although binding
was observed when the protein was grown and assayed at 30 °C. The
incubation for the ﬁlter binding experiments shown here was done at
4 °C.
Importinα5 binds to NPwith an afﬁnity similar to other importin–
cargo complexes (Yang et al., 2010). Two importin binding sites have
been proposed on NP, a monopartite N-terminal region (residues
1–13) and a bipartite motif located between amino acids 198-KR-199
and 213-RKTR-216. Because the bipartite signal overlaps with the
putative RNA binding platform (Ng et al., 2008) and because importin
binding has no effect on RNA binding of NP, it is most likely that the
N-terminal NLS is used. Recombinant NP in the NP-importin complex
is monomeric, like the R416A and E339A mutants but has the same
afﬁnity for RNA as free recNP. This implies that it is not the fact that
the twomutants are monomeric that lowers the afﬁnity for RNA by 20
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mutations have an inﬂuence on the structure of the RNA binding
platform or that they do not allow possible conformational changes in
NP upon RNA binding.
Finally, the non-segmented RNA viruses code for a phosphoprotein
that, as one of its functions, keeps the viral nucleoprotein soluble and
prevents it from binding to non-viral RNA before it is delivered onto the
newlyproduced viral or complementaryRNA (Albertini et al., 2008).We
had hypothesized that importinα could fulﬁl the same function but our
RNA binding experiments using the NP–importin complex show that
this is not the case. However, importin binding to NP may prevent
oligomerization of NP in the nucleus and, as such, perform a chaperone
function during the inﬂuenza virus infection process.
Materials and methods
Recombinant NP proteins
The nucleoprotein gene from inﬂuenza virus A/PR/8/34 (recNP for
recombinant NP), which codes for a 498-residue protein, was
expressed using a recombinant plasmid pET-16b (Novagen) contain-
ing the full length gene with a His-Tag at its N-terminal end. To
remove the His-Tag, we changed the cleavage site Factor X to a TEV
site. The mutations R416A and E339A of NP were constructed by,
respectively, replacing the codons R416 and E339 to GCA coding for
alanine, using an inverse PCR method (Quickchange, Stratagene). E.
coli BL21 (DE3) pLysS (Stratagene) was used for protein expression.
Expression of the recombinant proteins was induced with 0.5 mM
isopropyl-1-thio-β-D-galactopyranoside (IPTG) for 5 h at 22 °C. Cells
were harvested by centrifugation and then resuspended in lysis buffer
containing 20 mM Tris–HCl, pH 7.9, 500 mM NaCl, 10 mM imidazole,
10% glycerol and 1 mM β-SH. After opening the cells by sonication, the
cell debris was removed by centrifugation for 1 h at 20,000g at 4 °C.
The supernatant was ﬁltered through a 0.2 μmmembrane and loaded
onto a Co2+ charged afﬁnity column (Sigma). The columnwaswashed
with 20 mM Tris–HCl, pH 7.9, 1 M NaCl, 10 mM imidazole, 10%
glycerol, 1 mM β-SH. NP was eluted with 500 mM imidazole and
dialysed against 20 mM Tris–HCl, pH 7.9, 200 mM NaCl, 10% glycerol
and 1 mM β-SH. When needed, the His-Tag was removed with TEV
protease (ratio 1/100) overnight at room temperature. The cut protein
was further puriﬁed by gel ﬁltration on a HiLoad 16/60 Superdex 200
column (GE Healthcare) equilibrated with 40 mM Tris–HCl, pH 7.5,
200 mM NaCl, 1 mM β-mercaptoethanol buffer. Puriﬁed protein was
at least 95% pure according to Coomassie SDS-polyacrylamide gel
electrophoresis.
Recombinant human importin α5
Human importin α5 (473-residues), was expressed using a
recombinant plasmid pProEX HTb (Invitrogen). The ﬁrst sixty-six
amino acid residueswere deleted as well as the last twenty. Expressed
importin α5 contains an N-terminal His-Tag provided by the vector
and a TEV cleavage site. The sequence of importin α5 gene was
veriﬁed by standard dideoxy sequencing. The plasmid was trans-
formed into E. coli BL21 competent cells (Stratagene). The cells were
grown in Luria–Bertoni medium at 37 °C until OD 600 nm reached 0.8.
Expression of the recombinant protein was then inducedwith 0.5 mM
isopropyl-1-thio-β-D-galactopyranoside (IPTG) for 5 h at 22 °C. Cells
were harvested by centrifugation and then suspended in lysis buffer
containing 20 mM Tris–HCl, pH 8.45, 100 mMNaCl, 10 mM imidazole,
10% glycerol and 1 mM β-mercaptoethanol. The cells were disrupted
by sonication on ice. The cell debris was removed by centrifugation for
1 h at 20,000g, 4 °C. The supernatant was ﬁltered over a 0.2 μm
membrane and loaded onto a Co2+ charged afﬁnity column (Sigma).
The column was washed with 20 mM Tris–HCl, pH 8.45, 500 mM
NaCl, 10 mM imidazole, 10% glycerol, 1 mM β-mercaptoethanol bufferand importinα5 protein was eluted with 500 mM imidazole. The His-
Tag was removed with TEV protease (1/100) overnight and then
puriﬁed by a gel ﬁltration chromatography on a HiLoad 16/60
Superdex 200 column (GE Healthcare) equilibrated with 40 mM
Tris–HCl, pH 7.5, 200 mM NaCl, 1 mM β-mercaptoethanol buffer. The
ﬂow rate was 2.5 ml/min and the A280nm was measured. The elution
volume of selected protein standards was used to construct a
calibration curve (data not shown). Puriﬁed importin α5 was at
least 95% pure according to Coomassie SDS-polyacrylamide gel
electrophoresis and had an A260nm/A280nm ratio of at least 0.6.
Complex formation between recNP and importin α5
After His-Tag removal, importinα5 and NPweremixed together in
a ratio : 3 Impα5/1 recNP (mole/mole). The mixture was loaded on a
Superdex 200 column in the buffer Tris–HCl (pH 7.5), 30 mM, NaCl
150 mM and β-SH 1 mM. The complex was eluted at a retention
volume of 14.6 ml. Samples were further visualized on a Coomassie
SDS PAGE stained gel.
Filter binding experiments
The method was described in Baudin et al. (1994). Brieﬂy, the
radiolabelled RNA was ﬁrst denatured in water at 95 °C for 1 min, and
then properly folded in the following buffer: 50 mM Tris–HCl (pH
7.5), 100 mM NaCl, 10 mM MgCl2 and 2.5 mM DTT. Protein samples
were serially diluted in the same buffer from 10−4 M to 10−9 M before
addition of ﬁxed amount of RNA. After an incubation of 1 h at 4 °C, the
mixture was ﬁltrated through a nitrocellulose ﬁlter. These ﬁlters were
counted in a Cerenkov scintillation counter.
Analytical ultracentrifugation
Sedimentation velocity experiments were done at 20 °C using
2-channel charcoal centerpices at 46,000 rpm in a Beckman Optima
XL-A centrifuge (Beckman-Coulter) ﬁtted with a four-hole AN-60Ti
rotor. Sedimentation velocity proﬁles were collected by monitoring
the absorbance signal at 280 nm in 40 mM Tris–HCl, pH 7.5, 200 mM
NaCl, 1 mM β-mercaptoethanol buffer. Sedimentation coefﬁcients
andmolecular weight distributions were analysed by the C(s) method
implemented in the Sedﬁt software package (Schuck, 2000). Buffer
density and viscosity corrections were made according to the data
published by Laue et al. (1992).
Isothermal titration calorimetry (ITC)
ITC was performed using a VP-ITC Microcal calorimeter (Microcal,
Northhampton, MA, USA). The protein was dialysed extensively
against ITC buffer (40 mM Tris–HCl, pH 7.5, 200 mM NaCl, 1 mM
β-mercaptoethanol) prior to all titrations. Experiments were per-
formed at 25 °C. A typical titration consisted of injecting 12 μL aliquots
of 50–70 μMof protein with a syringe into 5–7 μMprotein solutions in
the cell at time intervals of 5 min to ensure that the titration peak
returned to the baseline. ITC data were corrected for the heat of
dilution by subtracting of the mixing enthalpies for titrant solution
injections into protein-free buffer. The ITC data were analyzed using
program Origin version 5, provided by the manufacturer.
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